Daily FNArena News - Small Caps

Investor concerns around the impact of price changes implemented by Life360 in late 2022 have proven unwarranted, with trends normalising and the company moving closer to breakeven

Brokers are enthusiastic on the opportunity for Mader Group, particularly the growth possibilities in North America

Perenti has pleased analysts with a second upgrade to full year guidance in five weeks, as the company benefits from successfully negotiating improved contract terms

Brokers are bullish on prospects for SiteMinder following a share price swoon since listing on the ASX

Early investment sees APM Human Services outperform competitors as Workforce Australia gears up, while acquisition underpins future upside

Tim Boreham highlights opportunities for SaaS company Alcidion, which tracks patients through the medical system

Maas Group undergoes further strategic acquisition, expanding into the Melbourne market with the purchase of Dandy

Collins Foods has not surprised with its half year result, but updated guidance suggests anticipated second half margin recovery is no longer expected

Actinogen Medical is a biotech with a potentially “gazillion” dollar opportunity in its Alzheimer’s drug

A turn in sentiment has allowed Nanosonics shares to recover, with (some) broker views turning less negative